Moderna expanding kids vaccine study to better assess safety
WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Moderna expanding kids vaccine study to better assess safety
WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Moderna expanding kids vaccine study to better assess safety
WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Moderna expanding kids vaccine study to better assess safety
WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Some J&J vaccine doses can be used, but many must be tossed
U.S. regulators are allowing the release of about 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory, but many more doses can't be used and must be thrown out.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
Some J&J vaccine doses can be used, but many must be tossed
U.S. regulators are allowing the release of about 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory, but many more doses can't be used and must be thrown out.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
Some J&J vaccine doses can be used, but many must be tossed
U.S. regulators are allowing the release of about 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory, but many more doses can't be used and must be thrown out.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
Some J&J vaccine doses can be used, but many must be tossed
U.S. regulators are allowing the release of about 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory, but many more doses can't be used and must be thrown out.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
J&J vaccine doses to be released, but many will be tossed
U.S. regulators are allowing the release of 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory, but many other doses can't be used and must be thrown out.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
AP source: J&J doses to be released, but many will be tossed
U.S. regulators are allowing for the release of 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory, but material to make many more must be thrown out because of possible contamination, a person familiar with the decision told The Associated Press on Friday.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
Company producing J&J vaccine had history of violations
The company at the center of
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
Company producing J&J vaccine had history of violations
The company at the center of
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
Company producing J&J vaccine had history of violations
The company at the center of
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
Company producing J&J vaccine had history of violations
The company at the center of
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
Biden stands by May timeline for vaccines for all US adults
WASHINGTON (AP) — President Joe Biden said the U.S. expects to take delivery of enough coronavirus vaccine for all adults by the end of May — two months earlier than anticipated — and he pushed states to get at least one shot into the arms of teachers by the end …
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 8 MONTHS AGO
Biden stands by May timeline for vaccines for all US adults
WASHINGTON (AP) — President Joe Biden said the U.S. expects to take delivery of enough coronavirus vaccine for all adults by the end of May — two months earlier than anticipated — and he pushed states to get at least one shot into the arms of teachers by the end …
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 8 MONTHS AGO
Biden vows enough vaccine for all US adults by end of May
WASHINGTON (AP) — President Joe Biden said Tuesday the U.S. expects to take delivery of enough coronavirus vaccine for all adults by the end of May — two months earlier than anticipated — and he pushed states to get at least one shot into the arms of teachers by the …
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 8 MONTHS AGO
Biden vows enough vaccine for all US adults by end of May
WASHINGTON (AP) — President Joe Biden said the U.S. expects to take delivery of enough coronavirus vaccine for all adults by the end of May — two months earlier than anticipated — and he pushed states to get at least one shot into the arms of teachers by the end …
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 8 MONTHS AGO
White House: Merck to help produce rival J&J's vaccine
WASHINGTON (AP) — Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, the White House said Tuesday.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 8 MONTHS AGO
Hospitals can care for Medicare patients at home in pandemic
Hospitals will be allowed to care for Medicare patients in their own homes during the pandemic under a government program announced Wednesday to help hospitals deal with the latest surge.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Hospitals can care for Medicare patients at home in pandemic
Hospitals will be allowed to care for Medicare patients in their own homes during the pandemic under a government program announced Wednesday to help hospitals deal with the latest surge.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
1st drug for rare rapid-aging disease extends kids' lives
The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children, after studies showed it can extend their lives.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
1st drug for rare rapid-aging disease extends kids' lives
The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children, after studies showed it can extend their lives.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 12 MONTHS AGO
1st drug for rare rapid-aging disease extends kids' lives
The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children, after studies showed it can extend their lives.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 12 MONTHS AGO
1st drug for rare rapid-aging disease extends kids' lives
The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children, after studies showed it can extend their lives.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 12 MONTHS AGO
Pfizer: COVID-19 shot 95% effective, seeking clearance soon
Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to seek emergency use of limited shot supplies as the catastrophic outbreak worsens across the globe.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 12 MONTHS AGO
Pfizer: COVID-19 shot 95% effective, seeking clearance soon
Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to seek emergency use of limited shot supplies as the catastrophic outbreak worsens across the globe.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 12 MONTHS AGO
Pfizer says COVID-19 vaccine is looking 90% effective
Pfizer Inc. said Monday that its COVID-19 vaccine may be a remarkable 90% effective, based on early and incomplete test results that nevertheless brought a big burst of optimism to a world desperate for the means to finally bring the catastrophic outbreak under control.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
AP FACT CHECK: Trump’s claims on vaccine, election are wrong
WASHINGTON (AP) — Refusing to concede a
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Pfizer says COVID-19 vaccine is looking 90% effective
Pfizer Inc. said Monday that its COVID-19 vaccine may be a remarkable 90% effective, based on early and incomplete test results that nevertheless brought a big burst of optimism to a world desperate for the means to finally bring the catastrophic outbreak under control.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Pfizer says COVID-19 vaccine is looking 90% effective
Pfizer Inc. said Monday that its COVID-19 vaccine may be a remarkable 90% effective, based on early and incomplete test results that nevertheless brought a big burst of optimism to a world desperate for the means to finally bring the catastrophic outbreak under control.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Pfizer says early data signals COVID-19 vaccine is effective
Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Pfizer tops 3Q earnings views, makes progress on COVID shot
Drugmaker Pfizer, one of the leaders in the race to develop a COVID-19 vaccine, is tweaking its timeline for when it will know if its experimental two-dose vaccine works.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Strong sales of drugs, vaccines, propel Merck in 3Q
Drugmaker Merck, bouncing back from a $1.6 billion hit from the coronavirus pandemic in the second quarter, boosted its third-quarter profit by 55% and blew past Wall Street expectations. The strong result was due to sales slightly higher than a year ago, plus restrained spending and a one-time gain.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Pfizer tops 3Q earnings views, makes progress on COVID shot
Drugmaker Pfizer, one of the leaders in the race to develop a COVID-19 vaccine, is tweaking its timeline for when it will know if its experimental two-dose vaccine works.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Strong sales of drugs, vaccines, propel Merck in 3Q
Drugmaker Merck, bouncing back from a $1.6 billion hit from the coronavirus pandemic in the second quarter, boosted its third-quarter profit by 55% and blew past Wall Street expectations. The strong result was due to sales slightly higher than a year ago, plus restrained spending and a one-time gain.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
AstraZeneca, J&J resuming US tests of COVID-19 vaccines
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
AstraZeneca, J&J resuming US tests of COVID-19 vaccines
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
AstraZeneca, J&J resuming US tests of COVID-19 vaccines
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
AstraZeneca, J&J resuming US tests of COVID-19 vaccines
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
AstraZeneca resuming US testing of COVID-19 vaccine
AstraZeneca Inc. announced Friday that regulators are letting it resume testing of its COVID-19 vaccine candidate in the U.S.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
US regulators approve 1st treatment for Ebola virus
U.S. regulators Wednesday approved the first drug for the treatment of Ebola.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS, 1 MONTH AGO
US regulators approve 1st treatment for Ebola virus
U.S. regulators Wednesday approved the first drug for the treatment of Ebola.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS, 1 MONTH AGO
US regulators approve 1st treatment for Ebola
U.S. regulators Wednesday approved the first drug for the treatment of Ebola.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS, 1 MONTH AGO
J&J beats 3Q net views, hikes 2020 forecast, but shares fall
Despite the coronavirus pandemic hurting sales of most of its products, Johnson & Johnson boosted revenue slightly and doubled its third-quarter profit, mainly due to a huge litigation charge in the year-ago quarter.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS, 1 MONTH AGO
Possible safety issue spurs pause of COVID-19 antibody study
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that’s similar to a treatment President Donald Trump recently received.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS, 1 MONTH AGO
Possible safety issue spurs pause of COVID-19 antibody study
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that’s similar to a treatment President Donald Trump recently received.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS, 1 MONTH AGO
J&J beats 3Q net views, hikes 2020 forecast, but shares fall
Despite the coronavirus pandemic hurting sales of most of its products, Johnson & Johnson boosted revenue slightly and doubled its third-quarter profit, mainly due to a huge litigation charge in the year-ago quarter.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS, 1 MONTH AGO
Johnson & Johnson beats 3Q profit views, hikes 2020 forecast
Johnson & Johnson boosted revenue slightly and doubled its third-quarter profit, mainly due to a $4 billion charge for litigation costs in the year-ago quarter. The health care giant blew past Wall Street expectations and raised its financial forecast for the year.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS, 1 MONTH AGO
US nursing homes warn of looming shortage of masks and gowns
WASHINGTON (AP) — Many nursing homes risk running out of protective masks and gowns by next week because of the coronavirus, and at least one facility already had to resort to using plastic garbage bags to make gowns, an industry group warned Wednesday.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
US nursing homes warn of looming shortage of masks and gowns
WASHINGTON (AP) — Many nursing homes risk running out of protective masks and gowns by next week because of the coronavirus, and at least one facility already had to resort to using plastic garbage bags to make gowns, an industry group warned Wednesday.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
Hospitals fear shortage of ventilators for virus patients
U.S. hospitals bracing for a possible onslaught of coronavirus patients with pneumonia and other breathing difficulties could face a critical shortage of mechanical ventilators and health care workers to operate them.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
Hospitals fear shortage of ventilators for virus patients
U.S. hospitals bracing for a possible onslaught of coronavirus patients with pneumonia and other breathing difficulties could face a critical shortage of mechanical ventilators and health care workers to operate them.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
Pfizer maneuvers to protect Lipitor from generics
TRENTON, N.J. - Lipitor is so valuable that Pfizer is practically paying people to keep taking its blockbuster cholesterol medicine after generic competition hits the U.S. market this week.
COEUR D'ALENE PRESS | UPDATED 12 YEARS, 11 MONTHS AGO
Amgen recalls anemia drugs due to glass flakes
TRENTON, N.J. - Amgen Inc. is recalling some lots of its blockbuster Epogen and Procrit anemia treatments because the injected drugs may contain glass flakes that could cause blood clots, swelling of veins, immune system reactions and other problems.
COEUR D'ALENE PRESS | UPDATED 14 YEARS, 1 MONTH AGO
Prev
Next